Current advances in HIV vaccine preclinical studies using Macaque models

被引：14

作者：

Liang, Binhua ^{[1
,2
]}

Li, Hongzhao ^{[3
]}

Li, Lin ^{[1
]}

Omange, Robert Were ^{[3
]}

Hai, Yan ^{[3
]}

Luo, Ma ^{[1
,3
]}

机构：

[1] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada

[2] Univ Manitoba, Biochem & Med Genet, Winnipeg, MB, Canada

[3] Univ Manitoba, Med Microbiol & Infect Dis, Winnipeg, MB, Canada

来源：

VACCINE | 2019年 / 37卷 / 26期

关键词：

Vaccine; Macaque; Simian immunodeficiency virus; Repeated-low-dose challenge; Vaccine efficacy; SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; RHESUS MACAQUES; CYNOMOLGUS MACAQUES; SIV INFECTION; REVERSE-TRANSCRIPTASE; RIBONUCLEASE-ACTIVITY; GAG/POL/NEF VACCINE; SIVMAC239; INFECTION; PROTECTIVE EFFICACY;

D O I：

10.1016/j.vaccine.2019.04.094

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The macaque simian or simian/human immunodeficiency virus (SIV/SHIV) challenge model has been widely used to inform and guide human vaccine trials. Substantial advances have been made recently in the application of repeated-low-dose challenge (RLD) approach to assess SIV/SHIV vaccine efficacies (VE). Some candidate HIV vaccines have shown protective effects in preclinical studies using the macaque SIV/SHIV model but the model's true predictive value for screening potential HIV vaccine candidates needs to be evaluated further. Here, we review key parameters used in the RLD approach and discuss their relevance for evaluating VE to improve preclinical studies of candidate HIV vaccines. Crown Copyright (C) 2019 Published by Elsevier Ltd. All rights reserved.

引用

页码：3388 / 3399

页数：12

共 50 条

[31] HIV Vaccine Development: Strategies for Preclinical and Clinical Investigation
Shapiro, Stuart Z.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : 1401 - 1406
[32] Current preclinical models of brain metastasis
Drouin, Zacharie
Levesque, Flavie
Mouzakitis, Korina
Labrie, Marilyne
CLINICAL & EXPERIMENTAL METASTASIS, 2025, 42 (01)
[33] Current Methods In Preclinical Aneurysm Models
Gruter, Basil E.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2023, (199):
[34] Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine
Jones, Kathryn M.
Poveda, Cristina
Versteeg, Leroy
Bottazzi, Maria Elena
Hotez, Peter J.
EXPERT REVIEW OF VACCINES, 2022, 21 (09) : 1185 - 1203
[35] UPDATE ON PRECLINICAL STUDIES OF HIV VACCINES
VOGEL, FR
TRANSFUSION, 1994, 34 (08) : 730 - 731
[36] Simian immunodeficiency virus macaque models of HIV latency
Deere, Jesse D.
Schinazi, Raymond F.
North, Thomas W.
CURRENT OPINION IN HIV AND AIDS, 2011, 6 (01) : 57 - 61
[37] Preclinical studies of prototype Rabies DNA Vaccine
Ya. Ya. Tynio
G. V. Morozova
E. I. Yarigina
Russian Agricultural Sciences, 2017, 43 (2) : 180 - 185
[38] Scientific challenge and advances of the HIV vaccine research
Shao Y.
Shao, Yiming (yshao08@gmail.com), 1815, Chinese Academy of Sciences (62): : 1815 - 1822
[39] Advances in HIV-1 Vaccine Development
Gao, Yong
McKay, Paul E.
Mann, Jamie E. S.
VIRUSES-BASEL, 2018, 10 (04):
[40] Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology
Selby, Mark J.
Engelhardt, John J.
Johnston, Robert J.
Lu, Li-Sheng
Han, Minhua
Thudium, Kent
Yao, Dapeng
Quigley, Michael
Valle, Jose
Wang, Changyu
Chen, Bing
Cardarelli, Pina M.
Blanset, Diann
Korman, Alan J.
PLOS ONE, 2016, 11 (09):

← 1 2 3 4 5 →